This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Wiebke Svea Saal: Innovator in Pharmaceutical Compositions
Introduction
Wiebke Svea Saal is a notable inventor based in Basel, Switzerland. She has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compositions for active pharmaceutical ingredients.
Latest Patents
Wiebke holds 1 patent for her invention titled "Pharmaceutical compositions for basic or neutral, low molecular weight compounds." This invention provides innovative solid or liquid pharmaceutical preparations that include a basic or neutral, low molecular weight active pharmaceutical ingredient combined with the polymer Eudragit® EPO. These preparations are designed for oral or topical administration, showcasing her expertise in pharmaceutical formulation.
Career Highlights
Throughout her career, Wiebke has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. Her experience in these organizations has allowed her to refine her skills and contribute to significant advancements in drug formulation.
Collaborations
Wiebke has collaborated with esteemed colleagues such as Jochem Alsenz and Martin Kuentz. These partnerships have further enriched her research and development efforts in the pharmaceutical sector.
Conclusion
Wiebke Svea Saal is a pioneering inventor whose work in pharmaceutical compositions has the potential to impact the industry significantly. Her innovative approach and collaborations highlight her dedication to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile